Directors’ Dealings

ENGLISH DEUTSCH

Publication of Directors’ Dealings pursuant to § 15a WpHG

On this page you will find an overview of the share trading activities by WILEX AG subject to disclosure in accordance with § 15a WpHG.

Announcement dated 06.07.2017 – Dr. Jan Schmidt-Brand – correction

Announcement dated 06.07.2017 – NewMarket Venture Verwaltungs GmbH – correction

Announcement dated 06.07.2017 – NewMarket Venture Verwaltungs GmbH – correction

Announcement dated 06.07.2017 – dievini Hopp BioTech holding GmbH & Co. KG – correction

Announcement dated 06.07.2017 – dievini Hopp BioTech holding GmbH & Co. KG – correction

Announcement dated 23.05.2017 – NewMarket Venture Verwaltungs GmbH

Announcement dated 22.05.2017 – Prof. Dr. Andreas Pahl

Announcement dated 18.05.2017 – Dr. Georg F. Baur

Announcement dated 18.05.2017 – dievini Hopp BioTech holding GmbH & Co. KG

Announcement dated 18.05.2017 – NewMarket Venture Verwaltungs GmbH

Announcement dated 18.05.2017 – Dr. Jan Schmidt-Brand

Announcement dated 19.12.2016 – dievini Hopp BioTech holding GmbH & Co. KG

Announcement dated 19.12.2016 – Curacyte GmbH i.L.

Announcement dated 03.11.2016 – Prof. Dr. Andreas Pahl

Announcement dated 03.11.2016 – Prof. Dr. Andreas Pahl

Announcement dated 03.11.2016 – Prof. Dr. Andreas Pahl

Announcement dated 21.07.2016 – Prof. Dr. Andreas Pahl

Announcement dated 21.07.2016 – Prof. Dr. Andreas Pahl

Announcement dated 27.04.2016 – dievini Hopp BioTech holding GmbH & Co. KG

Announcement dated 21.04.2016 – Dr. Jan Schmidt-Brand

Announcement dated 19.04.2016 – dievini Hopp BioTech holding GmbH & Co. KG

 

Archive Directors’ Dealings 2006-2015

 

Seite gelesen: 559 | Heute: 2